Treatments & Interventions
Thalidomide
substance
Methylprednisolone acetate
substance
Muromonab-CD3
substance
Methylprednisolone
substance
Prednisone
substance
Tacrolimus
substance
Mycophenolate mofetil
substance
Daclizumab
substance
Mycophenolic acid
substance
Methylprednisolone sodium succinate
substance
Mycophenolate sodium
substance
Mycophenolate mofetil hydrochloride
substance
Methylprednisolone aceponate
substance
Obiltoxaximab
substance
Tacrolimus monohydrate
substance
Belumosudil
substance
Belumosudil mesilate
substance
Tacrolimus anhydrous
substance
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Related Conditions
Quick Facts
- SNOMED CT
- 234646005
- UMLS CUI
- C0018133
- Fully Specified Name
- Graft-versus-host disease (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 30
- Known Treatments
- 18
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.